Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: A practical perspective

Robert A. Bonomo, Peter S. Van Zile, Qing Li, Kenneth M. Shermock, William G. McCormick, Bruce Kohut

Research output: Contribution to journalArticlepeer-review

Abstract

Triple-antibiotic ointment (TAO) is a safe and effective topical agent for preventing Infections in minor skin trauma. The formulation contains neomycin, polymyxin B and bacitracin in a petrolatum base. TAO is active against the most common disease-causing pathogens found in wounds and on the skin and may be an attractive alternative to oral therapy in select circumstances. Resistance to TAO does not develop readily, and safety studies have shown that the risk of allergic sensitivity to TAO is low. Susceptibility profiles of TAO have remained relatively unchanged since its discovery. Prophylaxis or treatment with TAO should be considered as resistant organisms continue to emerge in the community and hospital setting.

Original languageEnglish (US)
Pages (from-to)773-782
Number of pages10
JournalExpert Review of Anti-Infective Therapy
Volume5
Issue number5
DOIs
StatePublished - Oct 1 2007

Keywords

  • Antibiotic resistance
  • Bacitracin
  • MRSA
  • Neomycin
  • Polymyxin B
  • Topical
  • Triple antibiotic ointment

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: A practical perspective'. Together they form a unique fingerprint.

Cite this